CODEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Codeine, and when can generic versions of Codeine launch?
Codeine is a drug marketed by Hikma, Lannett Co Inc, and Scherer Labs. and is included in six NDAs.
The generic ingredient in CODEINE is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CODEINE?
- What are the global sales for CODEINE?
- What is Average Wholesale Price for CODEINE?
Summary for CODEINE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Drug Prices: | Drug price information for CODEINE |
Drug Sales Revenues: | Drug sales revenues for CODEINE |
DailyMed Link: | CODEINE at DailyMed |


US Patents and Regulatory Information for CODEINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | CODEINE SULFATE | codeine sulfate | TABLET;ORAL | 022402-003 | Jul 16, 2009 | AB | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Scherer Labs | CODEINE, ASPIRIN, APAP FORMULA NO. 2 | acetaminophen; aspirin; codeine phosphate | CAPSULE;ORAL | 085640-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Hikma | CODEINE SULFATE | codeine sulfate | SOLUTION;ORAL | 202245-001 | Jun 30, 2011 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Lannett Co Inc | CODEINE SULFATE | codeine sulfate | TABLET;ORAL | 203046-003 | Jun 13, 2014 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |